🇺🇸 Boostrix® dTpa in United States

Boostrix® dTpa (Boostrix® dTpa) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Boostrix® dTpa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Boostrix® dTpa approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Boostrix® dTpa in United States?

Siegrist Claire-Anne is the originator. The local marketing authorisation holder may differ — check the official source linked above.